Can Borderline Spirometry Confirm COPD? When to Repeat?
At a Glance
A borderline post-bronchodilator FEV1/FVC ratio does not by itself confirm or rule out COPD. Because results near the cutoff can vary with age, test quality, illness, and effort, clinicians often repeat spirometry when you are stable and review other causes of symptoms.
In this answer
3 sections
A borderline spirometry result may need confirmation before a diagnosis is finalized. If your post-bronchodilator FEV1/FVC ratio is just around the diagnostic cutoff, repeating the test is often recommended to verify the result [1]. Spirometry is the standard test for identifying airflow obstruction, but a single borderline result does not automatically prove or exclude chronic obstructive pulmonary disease (COPD) [1]. Because lung function can fluctuate and the test requires forceful physical effort, a result near the threshold warrants a second look.
The Diagnostic Cutoff: Fixed Ratio vs. Lower Limit of Normal
To evaluate for COPD, doctors look at your FEV1/FVC ratio after you have taken a bronchodilator (an inhaler that opens your airways). FEV1 is the amount of air you can force out in one second, and FVC is the total amount of air you can force out completely. A low ratio establishes persistent airflow obstruction and supports a COPD diagnosis in the appropriate clinical context, such as having symptoms and a history of exposure to smoke or occupational hazards [2][1].
There are two different ways medical guidelines define the cutoff for obstruction, which can lead to confusion if your numbers are on the borderline:
| Criteria | How it Works | What it Means for You |
|---|---|---|
| The Fixed Ratio | Used by the GOLD guidelines, this sets the cutoff at an FEV1/FVC of less than 0.70 (70%) [2]. | Simple to use, but does not account for natural aging. It can overdiagnose COPD in older adults and underdiagnose it in younger adults [3]. |
| Lower Limit of Normal (LLN) | Recommended by the American Thoracic Society (ATS) and European Respiratory Society (ERS), this compares your result to a statistically calculated lower boundary (often the 5th percentile or a “z-score”) based on a reference equation for your age, height, and sex [4]. | Adjusts for natural lung changes over time, potentially reducing age-related misdiagnosis [3]. |
If your result is near 0.70, you may be classified differently depending on which criteria your doctor uses [2][4]. Clinical guidelines note that when the FEV1/FVC ratio falls between 0.60 and 0.80, the result may vary on a different day; therefore, repeating the spirometry is a guideline-based recommendation to verify the finding [1].
Why Test Results Can Fluctuate
Spirometry is an “effort-dependent” test. It relies on a forceful, exhausting exhalation that requires active coaching from a trained technician [5]. Several factors can make a maneuver unreliable:
- Test Quality: If you cough, stop blowing too early, or don’t take a deep enough breath, the results can be uninterpretable or inaccurate. For example, stopping too early can underestimate your FVC and falsely raise your ratio, potentially hiding an obstruction [6]. Doctors and technicians visually inspect the flow-volume and volume-time curves (the graphs generated during the test) to ensure the maneuver meets technical standards for acceptability and repeatability [5].
- Equipment Issues: The accuracy of the spirometer itself matters. Equipment calibration errors have been shown to mistakenly classify normal tests as obstructed [7].
- Recent Illness: Elective diagnostic spirometry is generally deferred during an acute respiratory infection (like COVID-19 or the flu) or a COPD exacerbation [8][9]. Lung function can change temporarily during these times, so testing should ideally wait until your clinician determines you are clinically stable [8]. (Note: If you are experiencing severe or rapidly worsening breathlessness, do not wait for a repeat test—seek urgent care immediately.)
- Medications: The testing laboratory uses a standardized bronchodilator protocol. Do not stop taking your prescribed inhalers before a test unless the testing team or your clinician specifically instructs you to do so.
Next Steps After a Borderline Result
If your results are borderline, or if the test report shows a poor quality grade, repeating the spirometry when you are feeling well is a practical and recommended next step [6][8]. A repeat test should be performed by trained staff with active coaching, using a well-calibrated machine [5].
Having a history of smoking or experiencing symptoms like shortness of breath does not establish COPD on its own; persistent airflow obstruction must be proven [1]. However, if your repeat spirometry is normal but you are still experiencing symptoms, your symptoms still need an explanation. Your doctor may evaluate you for other causes of breathlessness, such as asthma, cardiac disease, or deconditioning, and may order more comprehensive tests like lung volumes and diffusing capacity (DLCO), or imaging if clinically indicated [10][11].
Common questions in this guide
Can a borderline post-bronchodilator FEV1/FVC ratio diagnose COPD?
Why might the COPD cutoff differ between reports?
When should borderline spirometry be repeated?
Should I stop my inhaler before repeat spirometry?
What if repeat spirometry is normal but I still feel short of breath?
One line in your results can change your plan.
A borderline FEV1/FVC ratio may call for repeat spirometry before a COPD diagnosis is finalized. We check your results against the latest research to help you prepare for what’s next.
Related questions
Show more
Get notified when new evidence is published on chronic obstructive pulmonary disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Under- and over-diagnosis of COPD: a global perspective.
Ho T, Cusack RP, Chaudhary N, et al.
Breathe (Sheffield, England) 2019; (15(1)):24-35 doi:10.1183/20734735.0346-2018.
PMID: 30838057 - 2
The effect of a post-bronchodilator FEV1/FVC < 0.7 on COPD diagnosis and treatment: a regression discontinuity design.
Moffett AT, Halpern SD, Weissman GE
Respiratory research 2025; (26(1)):122 doi:10.1186/s12931-025-03198-6.
PMID: 40170167 - 3
The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms.
Meteran H, Miller MR, Thomsen SF, et al.
ERJ open research 2017; (3(4)) doi:10.1183/23120541.00110-2017.
PMID: 29250530 - 4
Fixed ratio or lower limit of normal for the FEV1 /VC ratio: relation to symptoms and extended lung function tests.
Wollmer P, Frantz S, Engström G, et al.
Clinical physiology and functional imaging 2017; (37(3)):263-269 doi:10.1111/cpf.12294.
PMID: 26443700 - 5
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.
Graham BL, Steenbruggen I, Miller MR, et al.
American journal of respiratory and critical care medicine 2019; (200(8)):e70-e88 doi:10.1164/rccm.201908-1590ST.
PMID: 31613151 - 6
Deep learning algorithm for visual quality assessment of the spirograms.
Waląg D, Soliński M, Kołtowski Ł, et al.
Physiological measurement 2023; (44(8)) doi:10.1088/1361-6579/acee41.
PMID: 37552997 - 7
Accuracy and Quality of Spirometry in Primary Care Offices.
Hegewald MJ, Gallo HM, Wilson EL
Annals of the American Thoracic Society 2016; (13(12)):2119-2124 doi:10.1513/AnnalsATS.201605-418OC.
PMID: 27598295 - 8
[Expert consensus on pulmonary function testing during the epidemic of coronavirus disease 2019].
,
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2020; (43(4)):302-307 doi:10.3760/cma.j.cn112147-20200225-00175.
PMID: 32129580 - 9
Electrical impedance tomography as a bedside assessment tool for COPD treatment during hospitalization.
Yang L, Gao Z, Cao X, et al.
Frontiers in physiology 2024; (15()):1352391 doi:10.3389/fphys.2024.1352391.
PMID: 38562620 - 10
Routine pulmonary lung function tests: Interpretative strategies and challenges.
Barkous B, Briki C, Boubakri S, et al.
Chronic respiratory disease 2024; (21()):14799731241307252 doi:10.1177/14799731241307252.
PMID: 39644209 - 11
[COPD - Importance of Lung Function Testing for Diagnosis and Treatment].
Windisch W, Criée CP
Deutsche medizinische Wochenschrift (1946) 2018; (143(8)):593-596 doi:10.1055/s-0043-123846.
PMID: 29649849
This page is for informational purposes only and does not constitute medical advice or diagnose COPD. Your clinician should interpret your spirometry and decide whether repeat testing or other evaluation is appropriate.